tradingkey.logo

Bionano Genomics Inc

BNGO
1.150USD
+0.025+2.22%
Close 02/06, 16:00ETQuotes delayed by 15 min
11.19MMarket Cap
LossP/E TTM

Bionano Genomics Inc

1.150
+0.025+2.22%

More Details of Bionano Genomics Inc Company

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc Info

Ticker SymbolBNGO
Company nameBionano Genomics Inc
IPO dateAug 01, 2018
CEOHolmlin (R. Erik)
Number of employees98
Security typeOrdinary Share
Fiscal year-endAug 01
Address9540 Towne Centre Drive
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18588887600
Websitehttps://bionano.com/
Ticker SymbolBNGO
IPO dateAug 01, 2018
CEOHolmlin (R. Erik)

Company Executives of Bionano Genomics Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%
By RegionUSD
Name
Revenue
Proportion
EMEIA
3.63M
49.30%
Americas
2.85M
38.62%
Asia Pacific
890.00K
12.08%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
Other
81.77%
Shareholders
Shareholders
Proportion
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
Other
81.77%
Shareholder Types
Shareholders
Proportion
Investment Advisor
6.35%
Hedge Fund
5.39%
Corporation
5.16%
Individual Investor
3.19%
Investment Advisor/Hedge Fund
0.37%
Research Firm
0.10%
Other
79.44%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
2023Q3
336
90.39K
20.40%
+284.00
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Lincoln Alternative Strategies LLC
525.00K
5.16%
+525.00K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.67%
+475.00K
--
Sep 16, 2025
Abbe (Richard)
322.53K
3.17%
+322.53K
--
Sep 30, 2025
Iroquois Capital Management, LLC
194.66K
1.91%
+194.66K
--
Sep 30, 2025
The Vanguard Group, Inc.
50.46K
0.5%
+50.46K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
26.84K
0.26%
+7.97K
+42.22%
Sep 30, 2025
Carret Asset Management, LLC
25.00K
0.25%
+25.00K
--
Sep 30, 2025
HRT Financial LP
20.33K
0.2%
+20.33K
--
Sep 30, 2025
Two Sigma Investments, LP
15.58K
0.15%
+15.58K
--
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI